A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.
STATEN ISLAND, N.Y. — A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug Administration (FDA), which says consuming the product could “cause serious adverse health consequences or death.”
A recall which was issued across nine states has now been given the highest risk classification by the federal agency.
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,
Broccoli florets sold in Walmart stores across 20 states that were recalled over bacterial contamination fears have been given the U.S. Food and Drug Administration (FDA)'s highest risk level.
Trump's FDA moved to squash a proposed rule to ban menthol cigarettes just one day after the president was sworn in, angering anti-smoking advocates.
The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause adverse health consequences. In December, Texas-based food manufacturer Frito Lay recalled a limited number of Lay’s Classic 13oz because the product could contain undeclared milk ingredients.
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most were in favor of the change and agreed that, if finalized, the labels would help them make better-informed nutrition choices.
(Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with certain patient monitors from Contec and Epsimed and urged healthcare facilities to mitigate those risks.